Mathis Grossmann

12.5k total citations · 3 hit papers
198 papers, 8.8k citations indexed

About

Mathis Grossmann is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mathis Grossmann has authored 198 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Endocrinology, Diabetes and Metabolism, 42 papers in Pulmonary and Respiratory Medicine and 39 papers in Molecular Biology. Recurrent topics in Mathis Grossmann's work include Hormonal and reproductive studies (92 papers), Pharmacology and Obesity Treatment (37 papers) and Muscle metabolism and nutrition (28 papers). Mathis Grossmann is often cited by papers focused on Hormonal and reproductive studies (92 papers), Pharmacology and Obesity Treatment (37 papers) and Muscle metabolism and nutrition (28 papers). Mathis Grossmann collaborates with scholars based in Australia, United States and United Kingdom. Mathis Grossmann's co-authors include Jeffrey D. Zajac, Tae H. Ji, Inhae Ji, Rachel A. Davey, Rudolf Hoermann, Peter Angus, Ada S. Cheung, Paul Gow, Steve Gerondakis and Marie Sinclair and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Mathis Grossmann

192 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

G Protein-coupled Receptors

1998 1.1k citations Mathis Grossmann et al. profile →
Androgen Receptor Structure, Function and Biology: From Bench to Bedside.

2016 481 citations Rachel A. Davey, Mathis Grossmann profile →
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

2020 213 citations Gary Wittert, Karen Bracken et al. profile →

Peers

Countries citing papers authored by Mathis Grossmann

Since Specialization

Citations

This map shows the geographic impact of Mathis Grossmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathis Grossmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathis Grossmann more than expected).

Fields of papers citing papers by Mathis Grossmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathis Grossmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathis Grossmann. The network helps show where Mathis Grossmann may publish in the future.

Co-authorship network of co-authors of Mathis Grossmann

This figure shows the co-authorship network connecting the top 25 collaborators of Mathis Grossmann. A scholar is included among the top collaborators of Mathis Grossmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathis Grossmann. Mathis Grossmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic algorithm of hyponatremia 2025 ·Best Practice & Research Clinical Endocrinology & Metabolism ·(unknown), Mathis Grossmann, Annabelle M Warren	0
2	Testosterone in prevention and treatment of type 2 diabetes in men: Focus on recent randomized controlled trials 2024 ·Annals of the New York Academy of Sciences ·Mathis Grossmann, Gary Wittert	1
3	7700 Two Years Of Testosterone Therapy Reduces Glycemia In Males At High Risk Of Type 2 Diabetes Without Affecting Beta Cell Function: Results From A Randomised Controlled Trial And Cellular Model 2024 ·Journal of the Endocrine Society ·Mahesh M. Umapathysivam, Sameena Nawaz, Kristy Robledo, Carolyn A Allan, (unknown), Mathis Grossmann, David J. Handelsman, Warrick J. Inder, David Jesudason, Bronwyn Stuckey, Bu B. Yeap, (unknown), Alicia J. Jenkins, Ann J. Conway, Benoît Hastoy, Gary Wittert	1
4	Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial 2024 ·Journal of Clinical Oncology ·Sabashini K. Ramchand, Ali Ghasemzadeh, Rudolf Hoermann, Shane White, Belinda Yeo, Prudence A. Francis, (unknown), Olivia I. Coleman, Catherine Shore‐Lorenti, Peter R. Ebeling, Jeffrey D. Zajac, Ego Seeman, Mathis Grossmann	3
5	Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled Trial 2024 ·The Journal of Clinical Endocrinology & Metabolism ·Mathis Grossmann, Kristy Robledo, Mark Daniel, David J. Handelsman, Warrick J. Inder, Bronwyn Stuckey, Bu B. Yeap, Mark Ng Tang Fui, Karen Bracken, Carolyn A Allan, David Jesudason, Jeffrey D. Zajac, Gary Wittert	6
6	The Utility of Preclinical Models in Understanding the Bone Health of Transgender Individuals Undergoing Gender-Affirming Hormone Therapy 2023 ·Current Osteoporosis Reports ·(unknown), (unknown), Jeffrey D. Zajac, Mathis Grossmann, Rachel A. Davey	4
7	Pituitary abscess: a case report and systematic review of 488 cases 2023 ·Orphanet Journal of Rare Diseases ·(unknown), Yi Chao Foong, (unknown), (unknown), Jeffrey D. Zajac, Mathis Grossmann, (unknown), (unknown), (unknown)	9
8	Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study 2022 ·Endocrine Connections ·Brendan J. Nolan, (unknown), Shalem Leemaqz, (unknown), Mathis Grossmann, Jeffrey D. Zajac, Ada S. Cheung	8
9	Primary hyperparathyroidism in adults—(Part II) surgical management and postoperative follow‐up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society 2021 ·Clinical Endocrinology ·Julie Ann Miller, Justin S. Gundara, Simon Harper, (unknown), Sabashini K. Ramchand, Stephen Farrell, Jonathan W. Serpell, Kim Taubman, (unknown), Christian M. Girgis, Hans G. Schneider, Roderick Clifton‐Bligh, Anthony J. Gill, Sunita M C De Sousa, Richard Carroll, Frances Milat, Mathis Grossmann	4
10	Prevalence of polycythaemia with different formulations of testosterone therapy in transmasculine individuals 2020 ·Internal Medicine Journal ·Brendan J. Nolan, Shalem Leemaqz, (unknown), Pauline Cundill, (unknown), Peter Locke, Mathis Grossmann, Jeffrey D. Zajac, Ada S. Cheung	20
11	A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial 2019 ·Clinical Trials ·Karen Bracken, Anthony Keech, Wendy Hague, Carolyn A Allan, Ann J. Conway, Mark Daniel, Val Gebski, Mathis Grossmann, David J. Handelsman, Warrick J. Inder, Alicia J. Jenkins, Robert I. McLachlan, Kristy Robledo, Bronwyn Stuckey, Bu B. Yeap, Gary Wittert	1
12	Assessment and management of bone health in women with oestrogen receptor‐positive breast cancer receiving endocrine therapy: position statement summary 2019 ·The Medical Journal of Australia ·Mathis Grossmann, Sabashini K. Ramchand, Frances Milat, Amanda Vincent, Elgene Lim, Mark A. Kotowicz, (unknown), Helena Teede	16
13	Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies 2019 ·Trials ·Karen Bracken, Wendy Hague, Anthony Keech, Ann J. Conway, David J. Handelsman, Mathis Grossmann, David Jesudason, Bronwyn Stuckey, Bu B. Yeap, Warrick J. Inder, Carolyn A Allan, Robert I. McLachlan, Kristy Robledo, Gary Wittert	24
14	Assessment and management of bone health in women with oestrogen receptor‐positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia 2018 ·Clinical Endocrinology ·Mathis Grossmann, Sabashini K. Ramchand, Frances Milat, Amanda Vincent, Elgene Lim, Mark A. Kotowicz, (unknown), Helena Teede	26
15	A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management 2017 ·The Journal of Clinical Endocrinology & Metabolism ·Mathis Grossmann, Alvin M. Matsumoto	154
16	Effect of Testosterone Treatment on Glucose Metabolism in Men With Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2014;37:2098-2107 2014 ·Diabetes Care ·Emily Gianatti, Rudolf Hoermann, Mathis Grossmann	1
17	Low-Serum Testosterone Levels Pre-Liver Transplantation Are Associated With Reduced Rates of Early Acute Allograft Rejection in Men 2014 ·Transplantation ·Marie Sinclair, Peter Angus, Paul Gow, Rudolf Hoermann, (unknown), Mathis Grossmann	3
18	Hypothyroidism: Investigation and management 2012 ·Michelle So, Richard J. MacIsaac, Mathis Grossmann	5
19	A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma 2012 ·Journal of Molecular Medicine ·Felipe Lorenzo, Chunzhang Yang, Mark Ng Tang Fui, Hariprasad Vankayalapati, Zhengping Zhuang, Thanh Huynh, Mathis Grossmann, Karel Pacák, Josef T. Prchal	131
20	A rational design strategy for protein hormone superagonists 1998 ·Nature Biotechnology ·Mathis Grossmann, Holger Leitolf, Bruce D. Weintraub, Mariusz W. Szkudlinski	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact